Yamamoto N - Search Results

1

Phase I study of LY2181308, an antisense oligonucleotide against survivin, in patients with advanced solid tumors.

Tanioka M, Nokihara H, Yamamoto N, Yamada Y, Yamada K, Goto Y, Fujimoto T, Sekiguchi R, Uenaka K, Callies S, Tamura T. Tanioka M, et al. Among authors: yamamoto n. Cancer Chemother Pharmacol. 2011 Aug;68(2):505-11. doi: 10.1007/s00280-010-1506-7. Epub 2010 Nov 16. Cancer Chemother Pharmacol. 2011. PMID: 21079959 Clinical Trial.

2

Phase I study of continuous afatinib (BIBW 2992) in patients with advanced non-small cell lung cancer after prior chemotherapy/erlotinib/gefitinib (LUX-Lung 4).

Murakami H, Tamura T, Takahashi T, Nokihara H, Naito T, Nakamura Y, Nishio K, Seki Y, Sarashina A, Shahidi M, Yamamoto N. Murakami H, et al. Among authors: yamamoto n. Cancer Chemother Pharmacol. 2012 Apr;69(4):891-9. doi: 10.1007/s00280-011-1738-1. Epub 2011 Nov 10. Cancer Chemother Pharmacol. 2012. PMID: 22071596 Clinical Trial.

3

Phase I and pharmacokinetic study of a new taxoid, RPR 109881A, given as a 1-hour intravenous infusion in patients with advanced solid tumors.

Kurata T, Shimada Y, Tamura T, Yamamoto N, Hyodo I, Saeki T, Takashima S, Fujiwara K, Wakasugi H, Kashimura M. Kurata T, et al. Among authors: yamamoto n. J Clin Oncol. 2000 Sep;18(17):3164-71. doi: 10.1200/JCO.2000.18.17.3164. J Clin Oncol. 2000. PMID: 10963645 Clinical Trial.

4

New strategies for cancer therapy in the 21st century.

Saito N, Tamura T, Yamamoto N, Nishio K. Saito N, et al. Among authors: yamamoto n. Cancer Chemother Pharmacol. 2001 Aug;48 Suppl 1:S102-6. doi: 10.1007/s002800100315. Cancer Chemother Pharmacol. 2001. PMID: 11587358 Review.

5

A phase I/II study of cisplatin and vinorelbine chemotherapy in patients with advanced non-small cell lung cancer.

Hotta K, Sekine I, Tamura T, Sawada M, Watanabe H, Kusaba H, Akiyama Y, Inoue A, Shimoyama T, Nokihara H, Ueda Y, Yamamoto N, Kunitoh H, Ohe Y, Kodama T, Saijo N. Hotta K, et al. Among authors: yamamoto n. Jpn J Clin Oncol. 2001 Dec;31(12):596-600. doi: 10.1093/jjco/hye129. Jpn J Clin Oncol. 2001. PMID: 11902490 Clinical Trial.

6

ZD0473 pharmacokinetics in Japanese patients: a Phase I dose-escalation study.

Murakami H, Tamura T, Yamada Y, Yamamoto N, Ueda Y, Shimoyama T, Saijo N. Murakami H, et al. Among authors: yamamoto n. Eur J Cancer. 2002 Dec;38 Suppl 8:S1-5. doi: 10.1016/s0959-8049(02)80012-0. Eur J Cancer. 2002. PMID: 12645906 Clinical Trial.

7

Phase I study of cisplatin analogue nedaplatin (254-S) and paclitaxel in patients with unresectable squamous cell carcinoma.

Sekine I, Nokihara H, Horiike A, Yamamoto N, Kunitoh H, Ohe Y, Tamura T, Kodama T, Saijo N. Sekine I, et al. Among authors: yamamoto n. Br J Cancer. 2004 Mar 22;90(6):1125-8. doi: 10.1038/sj.bjc.6601700. Br J Cancer. 2004. PMID: 15026789 Free PMC article. Clinical Trial.

8

Characteristics and outcomes of patients with advanced non-small-cell lung cancer who declined to participate in randomised clinical chemotherapy trials.

Tanai C, Nokihara H, Yamamoto S, Kunitoh H, Yamamoto N, Sekine I, Ohe Y, Tamura T. Tanai C, et al. Among authors: yamamoto n, yamamoto s. Br J Cancer. 2009 Apr 7;100(7):1037-42. doi: 10.1038/sj.bjc.6604982. Epub 2009 Mar 17. Br J Cancer. 2009. PMID: 19293799 Free PMC article.

9

Phase 1 study of lenvatinib combined with carboplatin and paclitaxel in patients with non-small-cell lung cancer.

Nishio M, Horai T, Horiike A, Nokihara H, Yamamoto N, Takahashi T, Murakami H, Yamamoto N, Koizumi F, Nishio K, Yusa W, Koyama N, Tamura T. Nishio M, et al. Among authors: yamamoto n. Br J Cancer. 2013 Aug 6;109(3):538-44. doi: 10.1038/bjc.2013.374. Epub 2013 Jul 16. Br J Cancer. 2013. PMID: 23860537 Free PMC article. Clinical Trial.

10

Safety and efficacy of nivolumab and standard chemotherapy drug combination in patients with advanced non-small-cell lung cancer: a four arms phase Ib study.

Kanda S, Goto K, Shiraishi H, Kubo E, Tanaka A, Utsumi H, Sunami K, Kitazono S, Mizugaki H, Horinouchi H, Fujiwara Y, Nokihara H, Yamamoto N, Hozumi H, Tamura T. Kanda S, et al. Among authors: yamamoto n. Ann Oncol. 2016 Dec;27(12):2242-2250. doi: 10.1093/annonc/mdw416. Epub 2016 Oct 20. Ann Oncol. 2016. PMID: 27765756 Free PMC article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

6,256 results

Search Page